Literature DB >> 23223446

Proinsulin intermolecular interactions during secretory trafficking in pancreatic β cells.

Leena Haataja1, Erik Snapp, Jordan Wright, Ming Liu, Alexandre B Hardy, Michael B Wheeler, Michele L Markwardt, Mark Rizzo, Peter Arvan.   

Abstract

Classically, exit from the endoplasmic reticulum (ER) is rate-limiting for secretory protein trafficking because protein folding/assembly occurs there. In this study, we have exploited "hPro-CpepSfGFP," a human proinsulin bearing "superfolder" green fluorescent C-peptide expressed in pancreatic β cells where it is processed to human insulin and CpepSfGFP. Remarkably, steady-state accumulation of hPro-CpepSfGFP and endogenous proinsulin is in the Golgi region, as if final stages of protein folding/assembly were occurring there. The Golgi regional distribution of proinsulin is dynamic, influenced by fasting/refeeding, and increased with β cell zinc deficiency. However, coexpression of ER-entrapped mutant proinsulin-C(A7)Y shifts the steady-state distribution of wild-type proinsulin to the ER. Endogenous proinsulin coprecipitates with hPro-CpepSfGFP and even more so with hProC(A7)Y-CpepSfGFP. Using Cerulean and Venus-tagged proinsulins, we find that both WT-WT and WT-mutant proinsulin pairs exhibit FRET. The data demonstrate that wild-type proinsulin dimerizes within the ER but accumulates at a poorly recognized slow step within the Golgi region, reflecting either slow kinetics of proinsulin hexamerization, steps in formation of nascent secretory granules, or other unknown molecular events. However, in the presence of ongoing misfolding of a subpopulation of proinsulin in β cells, the rate-limiting step in transport of the remaining proinsulin shifts to the ER.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23223446      PMCID: PMC3548498          DOI: 10.1074/jbc.M112.420018

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Human type 2 diabetes: morphological evidence for abnormal beta-cell function.

Authors:  C Sempoux; Y Guiot; D Dubois; P Moulin; J Rahier
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

Review 2.  Imaging molecular interactions in cells by dynamic and static fluorescence anisotropy (rFLIM and emFRET).

Authors:  D S Lidke; P Nagy; B G Barisas; R Heintzmann; J N Post; K A Lidke; A H A Clayton; D J Arndt-Jovin; T M Jovin
Journal:  Biochem Soc Trans       Date:  2003-10       Impact factor: 5.407

3.  An improved cyan fluorescent protein variant useful for FRET.

Authors:  Mark A Rizzo; Gerald H Springer; Butch Granada; David W Piston
Journal:  Nat Biotechnol       Date:  2004-02-29       Impact factor: 54.908

4.  A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications.

Authors:  Takeharu Nagai; Keiji Ibata; Eun Sun Park; Mie Kubota; Katsuhiko Mikoshiba; Atsushi Miyawaki
Journal:  Nat Biotechnol       Date:  2002-01       Impact factor: 54.908

5.  The vesicle docking protein p115 binds GM130, a cis-Golgi matrix protein, in a mitotically regulated manner.

Authors:  N Nakamura; M Lowe; T P Levine; C Rabouille; G Warren
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

6.  Oligomerization of green fluorescent protein in the secretory pathway of endocrine cells.

Authors:  R K Jain; P B Joyce; M Molinete; P A Halban; S U Gorr
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

7.  Imaging secretory vesicles by fluorescent protein insertion in propeptide rather than mature secreted peptide.

Authors:  Simon Watkins; Xuehui Geng; Lehong Li; Glenn Papworth; Paul D Robbins; Peter Drain
Journal:  Traffic       Date:  2002-07       Impact factor: 6.215

8.  Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion.

Authors:  H E Hohmeier; H Mulder; G Chen; R Henkel-Rieger; M Prentki; C B Newgard
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

9.  Aggregation and lack of secretion of most newly synthesized proinsulin in non-beta-cell lines.

Authors:  Yong Lian Zhu; Alexander Abdo; Joan F Gesmonde; Kathleen C Zawalich; Walter Zawalich; Priscilla S Dannies
Journal:  Endocrinology       Date:  2004-04-29       Impact factor: 4.736

10.  Severe block in processing of proinsulin to insulin accompanied by elevation of des-64,65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3.

Authors:  Xiaorong Zhu; Lelio Orci; Raymond Carroll; Christina Norrbom; Mariella Ravazzola; Donald F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

View more
  48 in total

1.  Endoplasmic reticulum oxidoreductin-1α (Ero1α) improves folding and secretion of mutant proinsulin and limits mutant proinsulin-induced endoplasmic reticulum stress.

Authors:  Jordan Wright; Julia Birk; Leena Haataja; Ming Liu; Thomas Ramming; Michael A Weiss; Christian Appenzeller-Herzog; Peter Arvan
Journal:  J Biol Chem       Date:  2013-09-10       Impact factor: 5.157

2.  Dominant protein interactions that influence the pathogenesis of conformational diseases.

Authors:  Jordan Wright; Xiaofan Wang; Leena Haataja; Aaron P Kellogg; Jaemin Lee; Ming Liu; Peter Arvan
Journal:  J Clin Invest       Date:  2013-06-03       Impact factor: 14.808

3.  Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro.

Authors:  Holger A Russ; Audrey V Parent; Jennifer J Ringler; Thomas G Hennings; Gopika G Nair; Mayya Shveygert; Tingxia Guo; Sapna Puri; Leena Haataja; Vincenzo Cirulli; Robert Blelloch; Greg L Szot; Peter Arvan; Matthias Hebrok
Journal:  EMBO J       Date:  2015-04-23       Impact factor: 11.598

4.  Cells Deploy a Two-Pronged Strategy to Rectify Misfolded Proinsulin Aggregates.

Authors:  Corey N Cunningham; Jeffrey M Williams; Jeffrey Knupp; Anoop Arunagiri; Peter Arvan; Billy Tsai
Journal:  Mol Cell       Date:  2019-06-05       Impact factor: 17.970

5.  Role of Proinsulin Self-Association in Mutant INS Gene-Induced Diabetes of Youth.

Authors:  Jinhong Sun; Yi Xiong; Xin Li; Leena Haataja; Wei Chen; Saiful A Mir; Li Lv; Rachel Madley; Dennis Larkin; Arfah Anjum; Balamurugan Dhayalan; Nischay Rege; Nalinda P Wickramasinghe; Michael A Weiss; Pamela Itkin-Ansari; Randal J Kaufman; David A Ostrov; Peter Arvan; Ming Liu
Journal:  Diabetes       Date:  2020-03-05       Impact factor: 9.461

6.  "Register-shift" insulin analogs uncover constraints of proteotoxicity in protein evolution.

Authors:  Nischay K Rege; Ming Liu; Balamurugan Dhayalan; Yen-Shan Chen; Nicholas A Smith; Leili Rahimi; Jinhong Sun; Huan Guo; Yanwu Yang; Leena Haataja; Nelson F B Phillips; Jonathan Whittaker; Brian J Smith; Peter Arvan; Faramarz Ismail-Beigi; Michael A Weiss
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

7.  Chromogranin B regulates early-stage insulin granule trafficking from the Golgi in pancreatic islet β-cells.

Authors:  Shelby C Bearrows; Casey J Bauchle; McKenzie Becker; Jonathan M Haldeman; Svetha Swaminathan; Samuel B Stephens
Journal:  J Cell Sci       Date:  2019-07-01       Impact factor: 5.285

8.  A fluorescent timer reporter enables sorting of insulin secretory granules by age.

Authors:  Belinda Yau; Lori Hays; Cassandra Liang; D Ross Laybutt; Helen E Thomas; Jenny E Gunton; Lindy Williams; Wayne J Hawthorne; Peter Thorn; Christopher J Rhodes; Melkam A Kebede
Journal:  J Biol Chem       Date:  2020-04-27       Impact factor: 5.157

Review 9.  Lessons from animal models of endocrine disorders caused by defects of protein folding in the secretory pathway.

Authors:  Yoshiaki Morishita; Peter Arvan
Journal:  Mol Cell Endocrinol       Date:  2019-10-09       Impact factor: 4.102

Review 10.  Misfolded proinsulin in the endoplasmic reticulum during development of beta cell failure in diabetes.

Authors:  Anoop Arunagiri; Leena Haataja; Corey N Cunningham; Neha Shrestha; Billy Tsai; Ling Qi; Ming Liu; Peter Arvan
Journal:  Ann N Y Acad Sci       Date:  2018-01-28       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.